Faculty Directory

Back to Search Results
Adam Friedman

Adam Friedman

Associate Professor of Dermatology

Office Phone: 202-741-2600
Department: Dermatology


  • BA, University of Pennsylvania, 2002
  • MD, Albert Einstein College of Medicine, 2006


Adam Friedman, MD, FAAD is an Associate Professor of Dermatology and serves as Residency Program Director and Director of Translational Research in the Department of Dermatology at The George Washington University School of Medicine & Health Sciences and George Washington Medical Faculty Associates. Dr. Friedman completed his undergraduate training at the University of Pennsylvania and graduated with Distinction in Dermatologic Research at the Albert Einstein College of Medicine in New York. He completed his internship at New York Hospital Queens, and returned to Einstein for his Dermatology residency and was appointed Chief Resident during his final year. Dr. Friedman joined the Einstein faculty after graduation from 2010-2015, during which time he was the Director of Dermatologic Research, Director of the Translational Research Fellowship, and the Associate Program Director.

Dr. Friedman’s clinical interests span the gamut of medical and pediatric dermatology, including acne, eczema, psoriasis, skin infections, hair loss, wound healing, urticaria, blistering diseases, lupus, sarcoidosis, and skin cancer to name a few. Dr. Friedman lectures extensively in both national and international forums, and serves on a myriad of committees and advisory boards. He is a dermatology expert for healthguru.com and everydayhealth.com, and hosts an online series titled “Ask an Expert.” 

Dr. Friedman is also committed to resident and medical education. He currently serves on the AAD Sulzberger Committee on Education as well as the Poster Task Force, and is the Senior Editor of the Dermatology In-Review Online Workshop and Director of the Oakstone Institute Dermatology Board Review. Dr. Friedman served as the Chair of the Dermatology Section of the New York Academy of Medicine and now as Vice Chair, and in line with his research interests, as the Vice President of the Nanodermatology Society. 


Valeant Research Grant, 2014-2015, $63,800 (PI)
Women’s Dermatologic Society Academic Research Award, 2014-2015, $10,000 (PI)
Feldstein Medical Foundation Research Award, 2014-2015, $60,000 (PI)
American Skin Association Medical Student Grant Targeting Skin Cancer, 2014-2015, $7,000 (PI)
Onset Research Grant, 2013 -2014, $18,850 (PI)
Valeant Research Grant, 2013 - 2014, $34,500 (PI)
National Institute of Occupational Safety and Health 2013-2014 $123,050.00  (co-PI)
Department of Defense/TATRC 2012 - 2013             $349,856 (co-PI)
AECOM Global Health Center Microgrant 2011-2012 $5,000 (PI)
Janssen Unrestricted Research Grant  2012 – 2013, $41,500 (PI)
Dermatology Foundation Career Development Award, 2011 – 2012, 2012-2013, 2013-2014 $55,000  (PI)
Dermatology Foundation Dermatologist Investigator Research Fellowship, 2010-2011, $30,000
Centocor Fellowship Grant, 2010-2011, $30,000
La Roche-Posay North American Foundation Award, 2009-2010, $10,000
Women’s Dermatologic Society Academic Research Grant 2009-2010, $8,000
American Society of Dermatologic Surgery Cutting Edge Research Grant Award, 2009-2010, $15,000.


Special Recognition Award, Division of Dermatology, Montefiore - Albert Einstein College of Medicine, 2015
American Academy of Dermatology Annual Meeting Poster Task Force Award – First Place, 2015
Nanoscience Research Leaders Award, 2015
American Dermatologic Association Young Leader Award, 2014
Vitals.com Compassionate Physician Award 2014
Superdoctors NY Rising Star Award 2013-2015
Feldstein Foundation Medical Research Award, 2014
JDD Leaders of Distinction Award, 2014
Journal of the American Academy of Dermatology Editorial Mentorship Program, 2013
American Academy of Dermatology Academic Leadership Program, 2012
Dermatology Foundation Career Development Award, 2011, 2012, 2013
Leo M. Davidoff Award for Outstanding Achievement in the Teaching of Medical Students, 2010
Dermatology Foundation Dermatologist Investigator Research Fellowship, 2010
MMC Young Investigators Symposium Award, 2010
ARTE Scholar Poster Competition Award, 2010
Cosmetic Surgery Forum Travel Scholarship, 2009
American Society for Dermatologic Surgery Resident Scholarship Award, 2009
Chief Academy, 2009
American Academy of Dermatology Everett C. Fox, MD Award, 2009  - First Place
La Roche-Posay North American Foundation Award, 2009 – First Place
Women’s Dermatologic Society Academic Research Grant, 2009
MMC Young Investigators Symposium, Parviz Lalezari Award for Research Excellence, 2009
CSCR/MWAFMR Trainee Travel Award, 2009
American Society of Dermatologic Surgery Cutting Edge Research Grant Award, 2008


Dr. Friedman is currently investigating novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation, and correcting vascular dysfunction. He holds several patents derived from these investigations, and has published over 130 papers/chapters and 2 textbooks on both his research as well as a variety of clinical areas in dermatology with an emphasis on emerging medical therapies. He has received awards from multiple organizations such as the American Dermatologic Association, American Academy of Dermatology, American Society for Dermatologic Surgery, Journal of Drugs in Dermatology and the La Roche Posay North American Foundation.

Examples of recent publicartions include:

  1. Mordorski B, Pelgrift R, Krausz A, Adler B, Batista A, Liang H, Gunther L, Clendaniel A, Harper S, Friedman JM, Nosanchuk JD, Nacharaju P, Friedman AJ. S-nitrosocaptopril Nanoparticles as Nitric Oxide-Liberating and Transnitrosylating Anti-infective Technology. Nanomedicine. 2015; 11(2): 283-291.
  2. Greisman L, Nguyen TM, Mann RE, Baganizi M, Jacobson M, Paccione GA, Friedman AJ, Lipoff JB.Feasibility and cost of a medical student proxy-based mobile teledermatology consult service with Kisoro, Uganda and Lago Atitlán, Guatemala. Int J Dermatol. 2014 Dec 29. 
  3. Nguyen TA, Patel PS, Viola KV, Friedman AJ. Pseudofolliculitis Barbae in Females:  A Clinical Perspective. Br J Dermatol. 2014 Dec 30.
  4. Rosen J, Landriscina A, Kutner A, Adler B, Krauz A, Nosanchuk D, Friedman A. Silver Sulfadiazine Retards Wound Healing in Mice via Alterations in Cytokine Expression. J Invest. Dermatol. Published online January 27th 2015.
  5. Charafeddine RA, Makdisi J, Schairer D, O'Rourke BP, Diaz-Valencia JD, Chouake J, Kutner A, Krausz A, Adler B, Nacharaju P, Liang H, Mukherjee S, Friedman JM, Friedman A, Nosanchuk JD, Sharp DJ. Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing.  J Invest Dermatol. 2015 Mar 10. doi: 10.1038/jid.2015.94. [Epub ahead of print]
  6. Adler B, Kraus AE, Landriscina A, Musaev T, Nosanchuk JD, Friedman AJ. Biafine topical emulsion accelerates excisional and burn wound healing in mice. Arch Dermatol Res. 2015 Mar 21. [Epub ahead of print]
  7. Baltazar LM, Karusz AE, Souza AC, Adler B, Landriscina A, Musaev T, Nosanchuk JD, Friedman AJ. Trichophyton rubrum is inhibited by free and nanoparticle encapsulated curcumin by induction of nitrosative stress after photodynamic activation. PLoS ONE 10(3): e0120179. doi:10.1371/journal. pone.0120179
  8. Akhavan A, Murphy-Cotorian B, and Friedman A. Pediatric Dermatology Training During Residency: A Survey of the 2014 Graduating Residents. Pediatr Dermatol. 2015 Mar 26. doi: 10.1111/pde.12565. [Epub ahead of print].
  9. Doerner J, Wen J, Xia Y, Blecher Paz K, Schairer D, Wu L, Chalmers SA, Izmirly P,Michaelson JS, Burkly LC, Friedman A, and Putterman C.TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus J Invest Dermatol doi:10.1038/jid.2015.124; accepted article preview online March 31, 2015
  10. Rosen J, Landriscina A, Adler B, Krausz A,Doerner J, Navati M, Gravekamp C, Nosanchuk J, Friedman A. Characterization and Assessment of Nanoencapsulated Sanguinarine Chloride as a Potential Treatment for Melanoma. J Drugs Dermatol. 2015;14(5):453-458.
  11. Ruiz ES, Ingram A, Landriscina A, Tian J, Kirsner RS, Friedman A. Identifying an Education Gap in Wound Care Training in United States Dermatology. J Drugs Dermatol. 2015. 14(7):716-720.
  12. Musaev T, Landriscina A, Rosen J, Friedman AJ. The Management of Burn Injuries by Dermatologist: A Single Center Pilot Study. J Drugs Dermatol. 2015. 14(7):721-724.
  13. Landriscina A, Musaev T, Rosen J, Ray A, Nacharaju P, Nosanchuk JD, Friedman AJ. N-acetylcysteine S-nitrosothiol Nanoparticles Prevent Wound Expansion and Accelerate Wound Closure in a Murine Burn Model. J Drugs Dermatol. 2015. 4(7):726-732.
  14. Landriscina A, Rosen J, Blecher-Paz K, Long L, Ghannoum M, Nosanchuk J, Friedman AJ. Nitric oxide-releasing nanoparticles as a treatment for cutaneous dermatophyte infections. Sci Lett 2015, 4: 193
  15. Landriscina A, Rosen J, Albanese J, Amin B, Friedman A. Identifying New Biologic Targets in Atopic Dermatitis: A Retrospective Histologic Analysis. J Am Acad Dermatol.  2015 Jul 10. pii: S0190-9622(15)01815-0.
  16. Qin M, Landriscina A, Rosen J, Wei G, Kao S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A, Harper S, Adler B, Krausz A, Friedman J, Nosanchuk J, Kim J, Friedman AJ. Nitric Oxide Releasing Nanoparticles Prevent Propionibacterium acnes Induced Inflammation by both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response. J Invest Dermatol. 2015 Jul 14.

Centers and Institutes

George Washington Institute for Nanotechnology


View publications by this faculty member from January 1, 2013 - present

Additional publications published before January 1, 2013 may be available within Himmelfarb Library's database.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the healthcare related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

  • Biogen
  • Encore Dermatology
  • Galderma
  • La Roche-Pousay
  • Novartis
  • Pfizer
  • Promius